Commercialization: Page 42

PharmaVoice Team/PharmaVoice

Tools of the Trade

N-of-One Launches App Sequencing Data Trending Now: As the life-sciences business continues to diversify across borders and new channels, the need for easily accessible and accurate HCO, HCP, and affiliation information has never been greater. N-of-One has launched Variant Interpreter, a cloud-ba...
By PharmaVoice Team • June 1, 2015
PharmaVoice Team/PharmaVoice

Pharma Trax

Uptake of Digital Records Not sufficient to Drive Better Care Trending now: Despite increased use of electronic medical records, fewer U.S. doctors believe it improves health outcomes. Most U.S. doctors are more proficient using electronic medical records (EMR) than they were two years ago, but f...
By PharmaVoice Team • June 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Biopharma Pool David Allsop Amicus Therapeutics Appoints Senior VP, International Amicus Therapeutics, a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has appointed David Allsop as senior VP, international. He is responsible for Amicus’ international organi...
By PharmaVoice Team • June 1, 2015
PharmaVoice Team/PharmaVoice

Patient Engagement: Not Just For Physicians Anymore

When Pfizer wanted to engage with people living with chronic pain, it used an online crowdsourcing model and social media campaign that connected thousands of people, from patients and caregivers, to nurses and doctors. In what was the first initiative of its kind by a pharmaceutical company, Pfi...
By Robin Robinson • June 1, 2015
PharmaVoice Team/PharmaVoice

C-Suite: Digital Agencies

Digital Agencies C-suite executives from some of the industry’s leading digital agencies provide their insights on where the greatest opportunities for innovation lie to improve digital marketing, the greatest challenges involved with digital media, and best practices for reaching stakeholders ...
By PharmaVoice Team • June 1, 2015
PharmaVoice Team/PharmaVoice

Endpoint-Based Protocol Development: An Outcomes-Based Approach to Clinical Trial Testing

A shift toward more targeted therapeutics, combined with the need to meet specific endpoints in clinical trials, has placed a significant emphasis on esoteric laboratory tests within the test menus employed in clinical trials. Biopharmaceutical companies and clinical research organizations have l...
By Mark Engelhart • June 1, 2015
PharmaVoice Team/PharmaVoice

Patient or Partner? Building An Innovative Relationship for the Future

The healthcare industry has struggled with many changes in the last 10 years, including the inevitable patent cliff, the emergence of patient advocacy, increased regulatory and healthcare reform, and the rising cost of doing business. However, even in this age of rapid innovation and adaptability...
By Marc Sirockman • June 1, 2015
PharmaVoice Team/PharmaVoice

How Do iComply? A Look at Regulatory Topics Surrounding the use of Mhealth Technology in Clinical Trials

The U.S. National Institutes of Health (NIH) Consensus Group has defined mHealth as “the use of mobile and wireless devices to improve health outcomes, health care services and health research." The mHealth landscape is expanding with over 97,000 apps (mobile applications) as of 2013. Yet the vas...
By Philip Coran • June 1, 2015
PharmaVoice Team/PharmaVoice

Extracting Maximum Value From Electronic Data Capture

Electronic data capture (EDC) has been employed for clinical trial data for many years and is encouraged by the FDA because it provides significant benefits to sponsors, investigators, and patients, including more accurate data that can be more easily shared and monitored, increased compliance wi...
By Zaher El-Assi • June 1, 2015
PharmaVoice Team/PharmaVoice

Which Patients Are Really at Risk For Becoming Non-Adherent?

If you’re targeting only the most obvious patients with your medication adherence programs, you’re missing out on a big opportunity. Quite often, outreach programs focus on individuals hovering around the 80% threshold for proportion of days covered (PDC). It makes sense. Why not use your resourc...
By Craig Schilling • June 1, 2015
PharmaVoice Team/PharmaVoice

Seeing the Big Picture With Visual Data Analytics

Pharmaceutical and biotechnology companies are facing a gigantic increase in data — not just in volume, but in complexity. The number of clinical trials in the National Institute of Health’s registry has jumped from 5,635 in 2000 to 183,991 in 2015 — an increase of more than 30 times. The data la...
By Greg Moody • June 1, 2015
PharmaVoice Team/PharmaVoice

Five Tips for Expediting Clinical Trial Recruitment and Enhancing Patient Retention

According to the National Institutes of Health (NIH), more than 80% of clinical trials in the United States fail to meet their patient recruitment timelines. These delays increase costs, deplete resources, and prolong the time to market introduction. Patient recruitment is challenging as it invol...
By Lou Shapiro • June 1, 2015
PharmaVoice Team/PharmaVoice

Everything You Wanted to Know About Pharmacovigilance But Have Been Afraid to Ask

From the time humans begin taking an investigational new drug, pharmacovigilance measures play a critical role in every phase of a product’s lifecycle. However, understanding pharmacovigilance requirements can be daunting even for seasoned industry pros. This overview will answer all the question...
By Veronique Basch • June 1, 2015
PharmaVoice Team/PharmaVoice

Letter from the Editor

In this month’s Forum, experts from multiple disciplines, from drug development to marketing, discuss the challenges and opportunities that technology is bringing to the table. AstraZeneca’s CIO David Smoley sums up the changing landscape neatly: “When it comes to IT, we cannot operate in a world...
By Taren Grom • May 1, 2015
PharmaVoice Team/PharmaVoice

On the Calendar

Coming Attractions DIA 2015, the 51st annual meeting, is the largest multidisciplinary event that brings together a global network of life-sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients. This year’s t...
By PharmaVoice Team • May 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Biopharma Pool Steven Ertel Dr. Matthew Sherman Acceleron Pharma Announces Executive Appointments and Promotions Acceleron Pharma, a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic candidates that regulate cellular growth...
By PharmaVoice Team • May 1, 2015
PharmaVoice Team/PharmaVoice

A 21st Century CEO Challenge: Technology

AstraZeneca made a bold move last year and took back control of its servers and networks that pertained to core drug development from outsourcing vendors, which led to a 90% reduction in the number of critical outages, and decreased incident response down to a few hours instead of several days. F...
By PharmaVoice Team • May 1, 2015
PharmaVoice Team/PharmaVoice

Marketing Through Storytelling

The art of storytelling relies on a series of events leading up to a heroic moment with a main character who audiences can relate to. This is a simple concept if one is selling watches, or cars, or soft drinks. But who wants to see himself in the center of a story about illness? Patients and phys...
By Robin Robinson • May 1, 2015
PharmaVoice Team/PharmaVoice

Spain Emerges From Recession

Spain is one of the five largest European Union economies or the fourth largest in the Eurozone, with a population of around 46.6 million. After battling an economic decline since 2008, Spain’s economy grew again in 2014, expanding 1.4%. As a pharmaceutical market, Spain is equivalent in scale to...
By Kim Ribbink • May 1, 2015
PharmaVoice Team/PharmaVoice

2015 HBA Rising Stars

Defining Leadership Steph Dreyer. Bayer HealthCare. The goal of my team is to deliver results, and I see my role as encouraging and enabling the team to do just that. So the qualities most important to me are about motivating and inspiring people, and ensuring they’re set up for success. This inc...
By PharmaVoice Team • May 1, 2015
PharmaVoice Team/PharmaVoice

2015 HBA Luminaries

The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...
By Taren Grom • May 1, 2015
PharmaVoice Team/PharmaVoice

C-Suite: Advertising Agencies

Ken Begasse Founder and CEO Concentric Health Experience Opportunities: Marketers need to move healthcare from a model of disruption to one of desire. Disruptive brand communications interrupt and irritate to gain awareness. But to make customers desire a brand and make them seek it out, we have ...
By PharmaVoice Team • May 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: mHealth: The Next Frontier

More than 90% of the world’s population has some type of mobile phone, according to the Society for Participatory Medicine, quoting data from the International Telecommunications Union and PEW research. mHealth will continue to be a major factor in technology and health in 2015, with new apps tha...
By Taren Grom • May 1, 2015
PharmaVoice Team/PharmaVoice

The Power of Mobile Apps in Healthcare

The year 2013 officially marked the arrival of mobile with more than 50% smartphone adoption in all major markets. Though many organizations had dabbled, mobile-first strategies catapulted to the top of nearly all marketing priority lists. But in the rush to adopt in 2014, industries have struggl...
By Matt Balogh • May 1, 2015
PharmaVoice Team/PharmaVoice

Context is The New Mobile

The Internet has forever changed the way we look at information. Unlike any other generation before, information, text, music, images, video, are accessible to us at no or little cost at a speed incomparable to any previous technology. Our perspective on access then hit a paradigm shift: mobile. ...
By Chris Cullmann • May 1, 2015